By: Chelsea Schneider, PharmD, BCPS Dr. Bailey Agee, PharmD Dr. Agee is an Outpatient Infectious Diseases Pharmacy Specialist at Carilion Clinic. He completed his PGY-1 residency at Self Regional Healthcare and his PGY-2 at Cone Health Moses Cone Hospital. His interests include Human Immunodeficiency Virus (HIV), and Outpatient Parenteral Antimicrobial Therapy. Recent Research includes: Evaluation of Routine Admission Human Immunodeficiency (HIV) Screening at a Not-for-Profi

By: Andrew Madon, PharmD Dr. Sylwia Marianski, PharmD Dr. Marianski is a Clinical Pharmacist at Endeavor Health Evanston Hospital. She completed her PGY-1 residency program at Endeavor Health Glenbrook Hospital (NorthShore University HealthSystem) and her Fellowship Program at Midwestern University Downers Grove Campus. Her interests include pharmacokinetics and pharmacodynamics of anti-infective agents, individualized dosing strategies to improve patient outcomes, and clinic

By: Dr. Orbie Ubaka, PharmD, BCPS, BCIDP Dr. Saeed Aldosari, PharmD, BCPS, BCIDP Dr. Aldosari is an Infectious Diseases Pharmacist and Health Outcomes Fellow at Nova Southeastern University College of Pharmacy. He completed his PGY-1 Pharmacy Practice Residency and PGY-2 Infectious Diseases Pharmacy Residency at Tufts Medicine MelroseWakefield Hospital, Melrose, MA. His interests include Antimicrobial stewardship, transitions of care, resistance modeling, diagnostic stewards

By: Kristina White, PharmD, BCPS, BCIDP Dr. Alyssa Cox, PharmD Dr. Cox is an Oncology Infectious Diseases Clinical Pharmacy Specialist at Memorial Hospital West. She completed her PGY-1 residency at AdventHealth Orlando and her PGY-2 residency in Infectious Diseases at Memorial Hospital West. Her interests include Immunocompromised populations and gram-negative resistance. Recent Research includes:  Assessment of Vancomycin versus Fidaxomicin for Treatment of First...

By: Cara Slaton, PharmD, BCIDP Samantha Sakdipanichkul, PharmD, AAHIVP Dr. Sakdipanichkul is a clinical pharmacist at Memorial Hospital West in Pembroke Pines, Florida. She also completed her PGY-1 residency as well as her PGY-2 residency in Infectious Diseases at Memorial Hospital West. Her interests include HIV/AIDS and antimicrobial resistance. Dr. Sakdipanichkul presented the following research at the 2024 MAD-ID Conference: Impact of Adding Metronidazole to Cefazolin f

By: Danielle Casaus Dr. Shah is an Infectious Diseases Clinical Pharmacy Specialist at Penn Medicine Lancaster General Hospital. He completed his PGY-1 pharmacy residency at Wellstar Atlanta Medical Center followed by his PGY-2 pharmacy residency in infectious disease at the University of Florida Health Shands Hospital. His research interests include antimicrobial stewardship, Gram-negative resistance, and diagnostic stewardship. Dr. Shah and colleagues recently explored th

By: Christen Arena, PharmD Dr. Jessica Mulbah is an Infectious Diseases Clinical Pharmacy Specialist at Virtua Health in New Jersey. She completed her PGY-1 residency at Temple University Hospital, Philadelphia, PA and her PGY-2 in at Henry Ford Hospital, Detroit, MI – Infectious Diseases. Her interests include Gram-negative infections, Antimicrobial resistance, HIV/AIDS, and Infectious disease and social determinants of health. New research published in Diagnostic Microbiol

By: Cara Slaton, PharmD, BCIDP Brian Lu, PharmD Dr. Brian Lu is a clinical and antimicrobial stewardship pharmacist at Stanford Health Care Tri-Valley. He completed his PGY-1 residency as well as his PGY-2 residency in Infectious Diseases at Stanford Health Care. His interests include therapeutic drug monitoring, and antimicrobial resistance. New research published in Open Forum Infectious Diseases! Combination Antifungal Therapy for Invasive Mucormycosis in Immunocomprom

By: Cara Slaton, PharmD, BCIDP Taryn Eubank, PharmD, BCIDP Dr. Taryn Eubank is an Assistant Professor at the University of Houston College of Pharmacy. She received her PharmD from Harding University College of Pharmacy and went on to complete a PGY-1 residency as well as a PGY-2 in Infectious Diseases at Houston Methodist. Following residency, she received a National Institute of Allergy and Infectious Diseases grant through the Gulf Coast Consortia Training Program in Antim

By: Cara Slaton, PharmD, BCIDP Sameer Alzaidi, PharmD, BCPS, BCIDP, AAHIVP Training: PGY-2 Infectious Diseases at Intermountain Health in Salt Lake City, Utah Current position: Infectious Diseases Clinical Pharmacist at Taif Health Cluster, PGY-1 Pharmacy Residency Program Director, and Clinical Pharmacy Manager at King Abdulaziz Specialist Hospital in Taif Health Cluster, Taif Saudi Arabia Interests: Immunocompromised infectious diseases, MDROs, and PK/PD Research presented